Cargando…
The Role of Graphene Oxide Nanocarriers in Treating Gliomas
Gliomas are the most common primary malignant tumors of the central nervous system, and their conventional treatment involves maximal safe surgical resection combined with radiotherapy and temozolomide chemotherapy; however, this treatment does not meet the requirements of patients in terms of survi...
Autores principales: | Wang, Bin, Guo, Hanfei, Xu, Haiyang, Chen, Yong, Zhao, Gang, Yu, Hongquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831729/ https://www.ncbi.nlm.nih.gov/pubmed/35155223 http://dx.doi.org/10.3389/fonc.2022.736177 |
Ejemplares similares
-
The Role of the Transcription Factor EGR1 in Cancer
por: Wang, Bin, et al.
Publicado: (2021) -
Research Progress and Challenges in the Treatment of Central Nervous System Metastasis of Non-Small Cell Lung Cancer
por: Wang, Bin, et al.
Publicado: (2021) -
Raman spectroscopy: A prospective intraoperative visualization technique for gliomas
por: Zhang, Yi, et al.
Publicado: (2023) -
Recent biomedical advancements in graphene oxide- and reduced graphene oxide-based nanocomposite nanocarriers
por: Bellier, Naline, et al.
Publicado: (2022) -
Global research trends and hotspots on glioma stem cells
por: Song, Sirong, et al.
Publicado: (2022)